4

Evaluación comparativa preliminar Abbott Real Time SARS-CoV-2, … · 2020-05-08 · SARS-CoV-2 en muestras de frotis nasofaríngeos y bucofaríngeos de pacientes con signos y síntomas

Download PDF Report

Upload
others
View
9
Download
0

Embed Size (px)

Citation preview

Page 1: Evaluación comparativa preliminar Abbott Real Time SARS-CoV-2, … · 2020-05-08 · SARS-CoV-2 en muestras de frotis nasofaríngeos y bucofaríngeos de pacientes con signos y síntomas

Page 2: Evaluación comparativa preliminar Abbott Real Time SARS-CoV-2, … · 2020-05-08 · SARS-CoV-2 en muestras de frotis nasofaríngeos y bucofaríngeos de pacientes con signos y síntomas

Page 3: Evaluación comparativa preliminar Abbott Real Time SARS-CoV-2, … · 2020-05-08 · SARS-CoV-2 en muestras de frotis nasofaríngeos y bucofaríngeos de pacientes con signos y síntomas

Page 4: Evaluación comparativa preliminar Abbott Real Time SARS-CoV-2, … · 2020-05-08 · SARS-CoV-2 en muestras de frotis nasofaríngeos y bucofaríngeos de pacientes con signos y síntomas

Life cycle of SARS-CoV SARS-CoV-2 - Microsoft · 2020. 5. 8. · SARS-CoV-2 Nucleocapsid protein (ARG70216, ARG70217) CoV Product (Cat. No) Human ACE2 ELISA Kit (ARG80959) ACE2 antibody

Life cycle of SARS-CoV SARS-CoV-2 - Microsoft · 2020. 5. 8. · SARS-CoV-2 Nucleocapsid protein (ARG70216, ARG70217) CoV Product (Cat. No) Human ACE2 ELISA Kit (ARG80959) ACE2 antibody

Documents

Online - Branchentagung SARS-CoV-2

Online - Branchentagung SARS-CoV-2

Documents

SARS-CoV-2 Specimens

SARS-CoV-2 Specimens

Documents

Coronavirus (SARS-CoV-2) – Empfehlungen für Hochschulen und ... - Uni … · 2020. 4. 29. · Coronavirus (SARS-CoV-2) in Hochschulen und Forschungseinrichtungen. Der SARS-CoV-2-Arbeitsschutzstandard

Coronavirus (SARS-CoV-2) – Empfehlungen für Hochschulen und ... - Uni … · 2020. 4. 29. · Coronavirus (SARS-CoV-2) in Hochschulen und Forschungseinrichtungen. Der SARS-CoV-2-Arbeitsschutzstandard

Documents

SARS-CoV-2AntigenTestKit(LFIA

SARS-CoV-2AntigenTestKit(LFIA

Documents

cobas SARS-CoV-2

cobas SARS-CoV-2

Documents

SARS-CoV, MERS-CoV y SARS-CoV-2: lo que se sabe de estos

SARS-CoV, MERS-CoV y SARS-CoV-2: lo que se sabe de estos

Documents

SARS-CoV-2-Arbeitsschutzregel - BAuA

SARS-CoV-2-Arbeitsschutzregel - BAuA

Documents

Antigen SARS-CoV-2

Antigen SARS-CoV-2

Documents

A natural mutation between SARS-CoV-2 and SARS-CoV

A natural mutation between SARS-CoV-2 and SARS-CoV

Documents

Documents

CERTEST SARS-CoV-2

CERTEST SARS-CoV-2

Documents

Coronavirusul SARS-CoV-2

Coronavirusul SARS-CoV-2

Documents

SARS-CoV-2 - WHO

SARS-CoV-2 - WHO

Documents

Eyalet Hükümetinin SARS-CoV-2

Eyalet Hükümetinin SARS-CoV-2

Documents

Recombinant SARS-CoV-2 Nucleocapsid Protein (Full Length ... of SARS-CoV-2 Pseudovirus (… · PSV01) is recombinant pseudotyped lentiviral particles containing SARS-CoV-2 spike protein

Recombinant SARS-CoV-2 Nucleocapsid Protein (Full Length ... of SARS-CoV-2 Pseudovirus (… · PSV01) is recombinant pseudotyped lentiviral particles containing SARS-CoV-2 spike protein

Documents

Research Paper environment modulation in pneumonia patients caused by SARS-CoV… · 2020-05-15 · CoV, MERS-CoV and SARS-CoV-2 SARS-CoV-2 shows 88% identity to the sequence of SARS-like

Research Paper environment modulation in pneumonia patients caused by SARS-CoV… · 2020-05-15 · CoV, MERS-CoV and SARS-CoV-2 SARS-CoV-2 shows 88% identity to the sequence of SARS-like

Documents

The roles of signaling pathways in SARS-CoV-2 infection ......The roles of signaling pathways in SARS‑CoV‑2 infection; lessons learned from SARS‑CoV and MERS‑CoV NimaHemmat

The roles of signaling pathways in SARS-CoV-2 infection ......The roles of signaling pathways in SARS‑CoV‑2 infection; lessons learned from SARS‑CoV and MERS‑CoV NimaHemmat

Documents

cobas SARS-CoV-2 Test For detection of SARS-CoV-2 · cobas® SARS-CoV-2 Test For detection of SARS-CoV-2 SARS-CoV-2 is a novel respiratory coronavirus that can cause severe pneumonia

cobas SARS-CoV-2 Test For detection of SARS-CoV-2 · cobas® SARS-CoV-2 Test For detection of SARS-CoV-2 SARS-CoV-2 is a novel respiratory coronavirus that can cause severe pneumonia

Documents

Lyra SARS-CoV-2 Assay Lyra Direct SARS-CoV-2 Assay

Lyra SARS-CoV-2 Assay Lyra Direct SARS-CoV-2 Assay

Documents

Documents

Sars Dan Mers -Cov

Sars Dan Mers -Cov

Documents

COVID-19 & PHYSIOTHERAPIE...Institut für Physiotherapie SARS-COV-2 • Virus = «SARS-CoV-2» • Krankheit = «COVID-19»• SARS-CoV-2 ist Teil der Familie der Coronaviren• menschliche

COVID-19 & PHYSIOTHERAPIE...Institut für Physiotherapie SARS-COV-2 • Virus = «SARS-CoV-2» • Krankheit = «COVID-19»• SARS-CoV-2 ist Teil der Familie der Coronaviren• menschliche

Documents

SARS-CoV-2 Surveillance

SARS-CoV-2 Surveillance

Documents

Theeecofcoonaiinfecion (SARS-CoV-2,MERS -CoV,andSARS -CoV

Theeecofcoonaiinfecion (SARS-CoV-2,MERS -CoV,andSARS -CoV

Documents

Xpert Xpress SARS-CoV-2/Flu/RSV Verification Guide Xpress SARS-CoV-2...2010/12/22 · Xpert ® Xpress SARS-CoV-2/Flu/RSV Verification Guide 4 Run a positive control for SARS-CoV-2,

Xpert Xpress SARS-CoV-2/Flu/RSV Verification Guide Xpress SARS-CoV-2...2010/12/22 · Xpert ® Xpress SARS-CoV-2/Flu/RSV Verification Guide 4 Run a positive control for SARS-CoV-2,

Documents

CORONAVIROSES: DO SARS-COV E MERS -COV AO SARS-COV-2

CORONAVIROSES: DO SARS-COV E MERS -COV AO SARS-COV-2

Documents

SARS-CoV-2 ORF1ab and N genes...SARS-CoV and MERS-CoV have caused more than 10,000 cumulative cases in the past two decades, with mortality rates of 34% MERS-CoV and 10% SARS-CoV

SARS-CoV-2 ORF1ab and N genes...SARS-CoV and MERS-CoV have caused more than 10,000 cumulative cases in the past two decades, with mortality rates of 34% MERS-CoV and 10% SARS-CoV

Documents

Chorus SARS-CoV-2

Chorus SARS-CoV-2

Documents

SARS-CoV-2 and ORF3a: Nonsynonymous …SARS-CoV-2, RaTG13, and pangolin CoV. A D173Y substitution was detected in one SARS-CoV-2 strain (EPI_ISL_419177; source, France; date, 22 March

SARS-CoV-2 and ORF3a: Nonsynonymous …SARS-CoV-2, RaTG13, and pangolin CoV. A D173Y substitution was detected in one SARS-CoV-2 strain (EPI_ISL_419177; source, France; date, 22 March

Documents